London-based healthtech startup Abtrace raises £2.1M to transform the detection and treatment of chronic and long-term conditions using machine learning

August 30, 2021

Abtrace , a London, UK-based healthtech startup, announced today it has raised £2.1 million in seed funding to transform how chronic and long-term health conditions are detected, monitored, and treated. This round was led by the Lisbon-based VC fund Faber, with participation from Ganexa Capital and includes £1m in project funding from Innovate UK.

Read the source article at Tech Startups
2021-08-26 13:50:05

Share This Story!